1st FDA-Approved Cancer Vaccine
Shares of Dendreon sharply higher today, with CNBC’s Bertha Coombs.
Tel: 407.377.PARK (7275)
| Email: Info [@] 50Park.com
Provenge is first FDA-Approved Cancer Vaccine
Shares of Dendreon sharply higher today, with CNBC’s Bertha Coombs.